As discussed, GLP-1 RAs have been shown to improve liver enzymes and hepatic fat accumulation as well as promote resolution of steatohepatitis in patients with NAFLD [106]. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.